KEAP1 and cancer: The mechanism of sustained NRF2 activation has been revealed in some hereditary cancer types [167] and is related to the effects on genes coding for metabolic enzymes which can in turn affect key cysteine residues on KEAP1 to disrupt NRF2 interaction.